Associations between antipsychotic use, substance use and relapse risk in patients with schizophrenia: real-world evidence from two national cohorts.
Markku LähteenvuoJurjen J LuykxHeidi TaipaleEllenor Mittendorfer-RutzAntti TanskanenAlbert BatallaJari TiihonenPublished in: The British journal of psychiatry : the journal of mental science (2022)
Clozapine and antipsychotic polytherapy are most strongly associated with reduced risk of developing SUDs among patients with schizophrenia, and with lower relapse rates among patients with both diagnoses.
Keyphrases